title: Acquired Type II von Willebrand Syndrome in Locally Advanced Bladder Cancer Successfully Treated With Intravenous Immunoglobulin and Chemotherapy.
authors.affiliation: Hematology, Hôpital d'Instruction des Armées Percy, Clamart, France. Electronic address: dumas.guillaume1@gmail.com.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Dumas
authors.affiliation: Medical Oncology, Henri Mondor Teaching Hospital, Assistance Publique Hôpitaux de Paris, Paris Est Créteil University, INSERM U955 Team 18, IMRB, Paris, France.
authors.forename: Benoit
authors.initials: B
authors.lastname: Rousseau
authors.affiliation: Medical Oncology, Institut Curie, Paris, France.
authors.forename: Manuel Jorge
authors.initials: MJ
authors.lastname: Rodrigues
authors.affiliation: Medical Oncology, Cochin Teaching Hospital, Assistance Publique Hôpitaux de Paris, Paris-Descartes University, Paris, France.
authors.forename: Camille
authors.initials: C
authors.lastname: Tlemsani
authors.affiliation: Medical Oncology, Cochin Teaching Hospital, Assistance Publique Hôpitaux de Paris, Paris-Descartes University, Paris, France.
authors.forename: François
authors.initials: F
authors.lastname: Goldwasser
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D011859:Radiography; D001749:Urinary Bladder Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D056728:von Willebrand Disease, Type 2 / Q000000981:diagnostic imaging* / Q000188:drug therapy; D000093542:Gemcitabine
chemical_list: D016756:Immunoglobulins, Intravenous; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000093542:Gemcitabine
keywords: Acquired Willebrand disease; Bladder carcinoma; Diagnosis; Hematuria; Intravenous immunoglobulin